CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Wood Gavin Chief Financial Officer | Sale | −96,000 | $0.01 | $950 | 0 |
| 2025-08-28 | Bertrand William C JR Chief Operating Officer | Sale | −207,000 | $0.01 | $2K | 986,352 |
| 2025-08-18 | Behbahani Ali Director | Sale | −14,671,794 | $0.01 | $176K | 0 |
| 2025-08-15 | Behbahani Ali Director | Sale | −4,828,206 | $0.01 | $53K | 14,671,794 |
| 2025-07-30 | EcoR1 Capital, LLC 10% owner | Sale | −27,433,338 | $0.10 | $2.8M | 100,371,882 |
| 2025-07-29 | EcoR1 Capital, LLC 10% owner | Sale | −2,687,460 | $0.10 | $272K | 127,805,220 |
| 2025-07-28 | EcoR1 Capital, LLC 10% owner | Sale | −33,931,740 | $0.11 | $3.8M | 130,492,680 |
| 2025-02-20 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-02-20 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-02-20 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-02-20 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-02-20 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-02-20 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +5,143,248 | 5,143,248 | ||
| 2025-02-20 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +3,428,832 | 3,428,832 | ||
| 2025-01-17 | Norry Elliot Chief Medical Officer | Sale | −5,584 | $0.58 | $3K | 7,510 |
Page 1 of 23 · 454 trades